Clinical Trials in Cleveland

Showing 2501-2520 of 19,775 trials

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

NCT04684719

Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize the hemostatic competency of whole blood relative to its age.

Hemorrhagic ShockTraumatic Injury

Jason Sperry1,020 participantsStarted Apr 2022

Birmingham, Alabama, United States • Louisville, Kentucky, United States • Jackson, Mississippi, United States +7 more locations

RECRUITINGNA< 1 mile

Evaluation of Cochlear (Promontory) Stimulation During Awake Ear Surgery (TONES Study)

NCT07402941

The goal of this clinical trial is to learn if short electrical signals can be heard in adult subjects who are otherwise having surgery on their ear. The main question it aims to answer is: Can an individual accurately hear different frequencies resulting from the short electrical signals?

Hearing Disorder

Auricle Health Inc.18 participantsStarted Jun 2025

Cleveland, Ohio, United States

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

Evaluation of Cochlear (Promontory) Stimulation During Awake Ear Surgery (TONES Study)

Find Trials by Condition in Cleveland

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

A Study of Navenibart in Participants With Hereditary Angioedema

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

A Study of AZD0120 in Autoimmune Diseases

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma